Search research articles
Contact Us
Filters
Showing results (101-110 of 132) with videos related to
Page
of 14
Sort By:
Nature Communications
|
March 30, 2018
Breast and pancreatic cancer interrupt IRF8-dependent dendritic cell development to overcome immune surveillance
Melissa A Meyer, John M Baer, Brett L Knolhoff, et al.
Gut
|
December 3, 2017
Targeting both tumour-associated CXCR2<sup>+</sup> neutrophils and CCR2<sup>+</sup> macrophages disrupts myeloid recruitment and improves chemotherapeutic responses in pancreatic ductal adenocarcinoma
Timothy M Nywening, Brian A Belt, Darren R Cullinan, et al.
International Journal of Radiation Oncology, Biology, Physics
|
July 3, 2025
Improving Stereotactic Body Radiation Therapy by Rewiring Immunosuppressive Neutrophils in Murine Pancreatic Ductal Adenocarcinoma
Joseph D Murphy, Gary Hannon, Bradley N Mills, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 9, 2013
Inflammatory monocyte mobilization decreases patient survival in pancreatic cancer: a role for targeting the CCL2/CCR2 axis
Dominic E Sanford, Brian A Belt, Roheena Z Panni, et al.
Journal of Cancer Therapy
|
October 4, 2013
A Study of Zoledronic Acid as Neo-Adjuvant, Perioperative Therapy in Patients with Resectable Pancreatic Ductal Adenocarcinoma
Dominic E Sanford, Matthew R Porembka, Roheena Z Panni, et al.
Advances in Radiation Oncology
|
January 17, 2022
Development of an Orthotopic Murine Model of Rectal Cancer in Conjunction With Targeted Short-Course Radiation Therapy
Taylor P Uccello, Sarah A Kintzel, Bradley N Mills, et al.
Cancer Research
|
December 11, 2012
Targeting tumor-infiltrating macrophages decreases tumor-initiating cells, relieves immunosuppression, and improves chemotherapeutic responses
Jonathan B Mitchem, Donal J Brennan, Brett L Knolhoff, et al.
Disease Models & Mechanisms
|
February 28, 2024
Smad4 restricts injury-provoked biliary proliferation and carcinogenesis
William B Alexander, Wenjia Wang, Margaret A Hill, et al.
Oncoimmunology
|
June 5, 2026
Local delivery of SBRT and IL-12 to murine PDAC tumors modulates hematopoiesis
Tara G Vrooman, Emily R Quarato, Gary Hannon, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 23, 2019
Purity Independent Subtyping of Tumors (PurIST), A Clinically Robust, Single-sample Classifier for Tumor Subtyping in Pancreatic Cancer
Naim U Rashid, Xianlu L Peng, Chong Jin, et al.
Page
of 14
Search research articles
Search
Showing results (101-110 of 132) with videos related to
Sort By:
Page
of 14
Nature Communications
|
March 30, 2018
Breast and pancreatic cancer interrupt IRF8-dependent dendritic cell development to overcome immune surveillance
Melissa A Meyer, John M Baer, Brett L Knolhoff, et al.
Gut
|
December 3, 2017
Targeting both tumour-associated CXCR2<sup>+</sup> neutrophils and CCR2<sup>+</sup> macrophages disrupts myeloid recruitment and improves chemotherapeutic responses in pancreatic ductal adenocarcinoma
Timothy M Nywening, Brian A Belt, Darren R Cullinan, et al.
International Journal of Radiation Oncology, Biology, Physics
|
July 3, 2025
Improving Stereotactic Body Radiation Therapy by Rewiring Immunosuppressive Neutrophils in Murine Pancreatic Ductal Adenocarcinoma
Joseph D Murphy, Gary Hannon, Bradley N Mills, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 9, 2013
Inflammatory monocyte mobilization decreases patient survival in pancreatic cancer: a role for targeting the CCL2/CCR2 axis
Dominic E Sanford, Brian A Belt, Roheena Z Panni, et al.
Journal of Cancer Therapy
|
October 4, 2013
A Study of Zoledronic Acid as Neo-Adjuvant, Perioperative Therapy in Patients with Resectable Pancreatic Ductal Adenocarcinoma
Dominic E Sanford, Matthew R Porembka, Roheena Z Panni, et al.
Advances in Radiation Oncology
|
January 17, 2022
Development of an Orthotopic Murine Model of Rectal Cancer in Conjunction With Targeted Short-Course Radiation Therapy
Taylor P Uccello, Sarah A Kintzel, Bradley N Mills, et al.
Cancer Research
|
December 11, 2012
Targeting tumor-infiltrating macrophages decreases tumor-initiating cells, relieves immunosuppression, and improves chemotherapeutic responses
Jonathan B Mitchem, Donal J Brennan, Brett L Knolhoff, et al.
Disease Models & Mechanisms
|
February 28, 2024
Smad4 restricts injury-provoked biliary proliferation and carcinogenesis
William B Alexander, Wenjia Wang, Margaret A Hill, et al.
Oncoimmunology
|
June 5, 2026
Local delivery of SBRT and IL-12 to murine PDAC tumors modulates hematopoiesis
Tara G Vrooman, Emily R Quarato, Gary Hannon, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 23, 2019
Purity Independent Subtyping of Tumors (PurIST), A Clinically Robust, Single-sample Classifier for Tumor Subtyping in Pancreatic Cancer
Naim U Rashid, Xianlu L Peng, Chong Jin, et al.
Page
of 14